In terms of common molecular signatures, both NSCs and glioma CSCs exhibit Y-box binding protein 1 (YB-1), Sox-2, Nestin and Msi1 expression which are lost upon differentiation (Fotovati et al., 2011; Chao et al., 2017). The gene discussed is SOX2; the disease is central nervous system cancer.